Assessment of human adipose‐derived stem cell on surface‐modified silicone implant to reduce capsular contracture formation

Abstract Medical devices made from poly(dimethylsiloxane) (PDMS)‐based silicone implants have been broadly used owing to their inert properties, biocompatibility, and low toxicity. However, long‐term implantation is usually associated with complications, such as capsular contracture due to excessive...

Full description

Bibliographic Details
Main Authors: Chanutchamon Sutthiwanjampa, Byung Ho Shin, Na Eun Ryu, Shin Hyuk Kang, Chan Yeong Heo, Hansoo Park
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Bioengineering & Translational Medicine
Subjects:
Online Access:https://doi.org/10.1002/btm2.10260
_version_ 1798016074820616192
author Chanutchamon Sutthiwanjampa
Byung Ho Shin
Na Eun Ryu
Shin Hyuk Kang
Chan Yeong Heo
Hansoo Park
author_facet Chanutchamon Sutthiwanjampa
Byung Ho Shin
Na Eun Ryu
Shin Hyuk Kang
Chan Yeong Heo
Hansoo Park
author_sort Chanutchamon Sutthiwanjampa
collection DOAJ
description Abstract Medical devices made from poly(dimethylsiloxane) (PDMS)‐based silicone implants have been broadly used owing to their inert properties, biocompatibility, and low toxicity. However, long‐term implantation is usually associated with complications, such as capsular contracture due to excessive local inflammatory response, subsequently requiring implant removal. Therefore, modification of the silicone surface to reduce a risk of capsular contracture has attracted increasing attention. Human adipose‐derived stem cells (hASCs) are known to provide potentially therapeutic applications for tissue engineering, regenerative medicine, and reconstructive surgery. Herein, hASCs coating on a PDMS (hASC‐PDMS) or itaconic acid (IA)‐conjugated PDMS (hASC‐IA‐PDMS) surface is examined to determine its biocompatibility for reducing capsular contracture on the PDMS surface. In vitro cell cytotoxicity evaluation showed that hASCs on IA‐PDMS exhibit higher cell viability than hASCs on PDMS. A lower release of proinflammatory cytokines is observed in hASC‐PDMS and hASC‐IA‐PDMS compared to the cells on plate. Multiple factors, including in vivo mRNA expression levels of cytokines related to fibrosis; number of inflammatory cells; number of macrophages and myofibroblasts; capsule thickness; and collagen density following implantation in rats for 60 days, indicate that incorporated coating hASCs on PDMSs most effectively reduces capsular contracture. This study demonstrates the potential of hASCs coating for the modification of PDMS surfaces in enhancing surface biocompatibility for reducing capsular contracture of PDMS‐based medical devices.
first_indexed 2024-04-11T15:44:59Z
format Article
id doaj.art-a541350cc4cb485cbb9571814fd65ee1
institution Directory Open Access Journal
issn 2380-6761
language English
last_indexed 2024-04-11T15:44:59Z
publishDate 2022-01-01
publisher Wiley
record_format Article
series Bioengineering & Translational Medicine
spelling doaj.art-a541350cc4cb485cbb9571814fd65ee12022-12-22T04:15:37ZengWileyBioengineering & Translational Medicine2380-67612022-01-0171n/an/a10.1002/btm2.10260Assessment of human adipose‐derived stem cell on surface‐modified silicone implant to reduce capsular contracture formationChanutchamon Sutthiwanjampa0Byung Ho Shin1Na Eun Ryu2Shin Hyuk Kang3Chan Yeong Heo4Hansoo Park5School of Integrative Engineering, Chung‐Ang University Seoul Republic of KoreaDepartment of Biomedical Engineering College of Medicine, Seoul National University Seoul Republic of KoreaSchool of Integrative Engineering, Chung‐Ang University Seoul Republic of KoreaDepartment of Plastic and Reconstructive Surgery Chung‐Ang University Hospital Seoul Republic of KoreaDepartment of Biomedical Engineering College of Medicine, Seoul National University Seoul Republic of KoreaSchool of Integrative Engineering, Chung‐Ang University Seoul Republic of KoreaAbstract Medical devices made from poly(dimethylsiloxane) (PDMS)‐based silicone implants have been broadly used owing to their inert properties, biocompatibility, and low toxicity. However, long‐term implantation is usually associated with complications, such as capsular contracture due to excessive local inflammatory response, subsequently requiring implant removal. Therefore, modification of the silicone surface to reduce a risk of capsular contracture has attracted increasing attention. Human adipose‐derived stem cells (hASCs) are known to provide potentially therapeutic applications for tissue engineering, regenerative medicine, and reconstructive surgery. Herein, hASCs coating on a PDMS (hASC‐PDMS) or itaconic acid (IA)‐conjugated PDMS (hASC‐IA‐PDMS) surface is examined to determine its biocompatibility for reducing capsular contracture on the PDMS surface. In vitro cell cytotoxicity evaluation showed that hASCs on IA‐PDMS exhibit higher cell viability than hASCs on PDMS. A lower release of proinflammatory cytokines is observed in hASC‐PDMS and hASC‐IA‐PDMS compared to the cells on plate. Multiple factors, including in vivo mRNA expression levels of cytokines related to fibrosis; number of inflammatory cells; number of macrophages and myofibroblasts; capsule thickness; and collagen density following implantation in rats for 60 days, indicate that incorporated coating hASCs on PDMSs most effectively reduces capsular contracture. This study demonstrates the potential of hASCs coating for the modification of PDMS surfaces in enhancing surface biocompatibility for reducing capsular contracture of PDMS‐based medical devices.https://doi.org/10.1002/btm2.10260antifibrotic propertycapsular contractureforeign body responsehuman adipose‐derived stem cellsitaconic acidpoly(dimethylsiloxane)
spellingShingle Chanutchamon Sutthiwanjampa
Byung Ho Shin
Na Eun Ryu
Shin Hyuk Kang
Chan Yeong Heo
Hansoo Park
Assessment of human adipose‐derived stem cell on surface‐modified silicone implant to reduce capsular contracture formation
Bioengineering & Translational Medicine
antifibrotic property
capsular contracture
foreign body response
human adipose‐derived stem cells
itaconic acid
poly(dimethylsiloxane)
title Assessment of human adipose‐derived stem cell on surface‐modified silicone implant to reduce capsular contracture formation
title_full Assessment of human adipose‐derived stem cell on surface‐modified silicone implant to reduce capsular contracture formation
title_fullStr Assessment of human adipose‐derived stem cell on surface‐modified silicone implant to reduce capsular contracture formation
title_full_unstemmed Assessment of human adipose‐derived stem cell on surface‐modified silicone implant to reduce capsular contracture formation
title_short Assessment of human adipose‐derived stem cell on surface‐modified silicone implant to reduce capsular contracture formation
title_sort assessment of human adipose derived stem cell on surface modified silicone implant to reduce capsular contracture formation
topic antifibrotic property
capsular contracture
foreign body response
human adipose‐derived stem cells
itaconic acid
poly(dimethylsiloxane)
url https://doi.org/10.1002/btm2.10260
work_keys_str_mv AT chanutchamonsutthiwanjampa assessmentofhumanadiposederivedstemcellonsurfacemodifiedsiliconeimplanttoreducecapsularcontractureformation
AT byunghoshin assessmentofhumanadiposederivedstemcellonsurfacemodifiedsiliconeimplanttoreducecapsularcontractureformation
AT naeunryu assessmentofhumanadiposederivedstemcellonsurfacemodifiedsiliconeimplanttoreducecapsularcontractureformation
AT shinhyukkang assessmentofhumanadiposederivedstemcellonsurfacemodifiedsiliconeimplanttoreducecapsularcontractureformation
AT chanyeongheo assessmentofhumanadiposederivedstemcellonsurfacemodifiedsiliconeimplanttoreducecapsularcontractureformation
AT hansoopark assessmentofhumanadiposederivedstemcellonsurfacemodifiedsiliconeimplanttoreducecapsularcontractureformation